Guardant Health (GH) debt: $1.5B
Guardant Health had $1.5B of long-term debt on Dec 31, 2025, including the part due within a year, up 31.6% from $1.1B a year earlier.
From Guardant Health's filings with the SEC · Read the filing · GH stock page
Guardant Health debt by year
#746 of 2,129 US companies by debt · See the full ranking
| Year ended | Debt | Change |
|---|---|---|
| Dec 31, 2025 | $1.5B | +32% |
| Dec 31, 2024 | $1.1B | – |
Debt of similar companies
Companies in the same industry as Guardant Health, by SEC industry code, with the closest debt. Each name opens the same page for that company.
| Company | Debt, latest year | Year ended |
|---|---|---|
| Quest Diagnostics | $5.7B | Dec 31, 2025 |
| Labcorp | $5.6B | Dec 31, 2025 |
| Guardant Health | $1.5B | Dec 31, 2025 |
| RadNet | $1.1B | Dec 31, 2025 |
| Fortrea | $1.1B | Dec 31, 2025 |
| Caris Life Sciences | $378M | Dec 31, 2025 |
| Celcuity | $138M | Dec 31, 2025 |
Questions and answers
What is Guardant Health's debt?
Guardant Health had $1.5B of long-term debt on Dec 31, 2025, including the part due within a year, up 31.6% from $1.1B a year earlier.
Numbers as reported in Guardant Health's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology